Clinical Trials Browser

Phase 3 × Olanzapine × Plasma cell × Clear all

NCT06588413 2024-11-22

FONDO-LOW

Phase 3 Recruiting

Multiple Myeloma, Nausea

NCT02939287 2024-10-22

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Phase 3 Completed

52 enrolled 11 charts

Nausea, Vomiting, Neoplasms, Plasma Cell